Physician profile
Thomas C Wald
NPI 1164438040
$689.69
in general payments reported to CMS, 2019-2025
14 companies · $86.39 in 2025
The $86.39 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $127 · 2022: $12.64 · 2023: $98.69 · 2024: $68.53 · 2025: $86.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.13 | 2019-2025 | Jascayd |
| Inogen, INC. | $93.65 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Glaxosmithkline, LLC. | $89.63 | 2019-2024 | Nucala |
| La Jolla Pharmaceutical Company | $83.00 | 2019 | |
| Mylan Specialty L.P. | $58.26 | 2019 | |
| Grifols USA, LLC | $48.16 | 2020-2023 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $38.69 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $30.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.45 | 2020 | |
| Pfizer INC. | $15.46 | 2020 | |
| Insmed, INC. | $15.46 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.56 | 2025 | |
| Philips North America LLC | $12.64 | 2022 | |
| Shire North American Group INC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.